Gloria Vachino, MS

Instructor, Medical Sciences & Education

(617) 638-5655
72 E. Concord St Housman (R)

Education

  • Tufts University, MS
  • University of Wales, BS

Classes Taught

  • GMS BT 208
  • GMS BT 591/592
  • GMS BT 594, 595

Publications

  • Published on 4/15/1997

    Lichtman AH, Ding H, Henault L, Vachino G, Camphausen R, Cumming D, Luscinskas FW. CD45RA-RO+ (memory) but not CD45RA+RO- (naive) T cells roll efficiently on E- and P-selectin and vascular cell adhesion molecule-1 under flow. J Immunol. 1997 Apr 15; 158(8):3640-50. PMID: 9103426.

    Read at: PubMed
  • Published on 11/1/1996

    Goetz DJ, Ding H, Atkinson WJ, Vachino G, Camphausen RT, Cumming DA, Luscinskas FW. A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism. Am J Pathol. 1996 Nov; 149(5):1661-73. PMID: 8909255.

    Read at: PubMed
  • Published on 9/15/1995

    Vachino G, Chang XJ, Veldman GM, Kumar R, Sako D, Fouser LA, Berndt MC, Cumming DA. P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem. 1995 Sep 15; 270(37):21966-74. PMID: 7545173.

    Read at: PubMed
  • Published on 12/17/1993

    Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G, Veldman GM, Bean KM, Ahern TJ, Furie B, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993 Dec 17; 75(6):1179-86. PMID: 7505206.

    Read at: PubMed
  • Published on 11/1/1993

    Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993 Nov 1; 178(5):1629-36. PMID: 7693853.

    Read at: PubMed
  • Published on 11/1/1992

    Atkins MB, Vachino G, Tilg HJ, Karp DD, Robert NJ, Kappler K, Mier JW. Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy. J Clin Oncol. 1992 Nov; 10(11):1802-9. PMID: 1403061.

    Read at: PubMed
  • Published on 11/15/1991

    Vachino G, Gelfand JA, Atkins MB, Tamerius JD, Demchak P, Mier JW. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes. Blood. 1991 Nov 15; 78(10):2505-13. PMID: 1824247.

    Read at: PubMed
  • Published on 11/15/1990

    Mier JW, Vachino G, Klempner MS, Aronson FR, Noring R, Smith S, Brandon EP, Laird W, Atkins MB. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood. 1990 Nov 15; 76(10):1933-40. PMID: 2242421.

    Read at: PubMed
  • Published on 1/1/1990

    Yamada Y, Kimball K, Okusawa S, Vachino G, Margolis N, Sohn JW, Li JJ, Wakabayashi G, McAdam K, Burke JF, et al. Cytokines, acute phase proteins, and tissue injury. C-reactive protein opsonizes dead cells for debridement and stimulates cytokine production. Ann N Y Acad Sci. 1990; 587:351-61. PMID: 2193581.

    Read at: PubMed
  • Published on 12/1/1988

    Vachino G, Heck LW, Gelfand JA, Kaplan MM, Burke JF, Berninger RW, McAdam KP. Inhibition of human neutrophil and Pseudomonas elastases by the amyloid P-component: a constituent of elastic fibers and amyloid deposits. J Leukoc Biol. 1988 Dec; 44(6):529-34. PMID: 3264008.

    Read at: PubMed

View 3 more publications: View full profile at BUMC

View all profiles